“…More recently, several authors have reported successful anatomic and visual outcomes with transconjunctival sutureless vitrectomy (TSV) in eyes with different vitreoretinal disorders, such as epiretinal membranes [13][14][15][16][17][18][19], macular holes [13,[15][16][17][18][19], vitreous hemorrhage [13,15,16,19,20], and proliferative diabetic retinopathy [13,16,17,19]. This technique gained favor with many vitreoretinal surgeons since complication rates are considered comparable to those reported with 20-gauge (20-G) systems [12,13,17], with less induced astigmatism [14,21] and reduced patient discomfort [18] but conflicting results concerning less surgically induced inflammation [14,22]. All of these studies suggest that 23-G instrumentation is safe and effective for performing vitreoretinal surgery.…”